SL
MRNA icon

Stevard LLC’s Moderna MRNA Stock Holding History

Stevard LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,350
Closed -$873K – 43
2024
Q2 		$873K Sell
7,350
-501
-6% -$63.4K 0.75% 21
2024
Q1 		$837K Hold
7,851
– – 0.75% 21
2023
Q4 		$781K Sell
7,851
-89
-1% -$7.49K 0.77% 20
2023
Q3 		$820K Sell
7,940
-26
-0.3% -$2.9K 0.83% 16
2023
Q2 		$968K Sell
7,966
-222
-3% -$29.6K 0.92% 15
2023
Q1 		$1.26M Hold
8,188
– – 1.18% 13
2022
Q4 		$1.47M Hold
8,188
– – 1.26% 10
2022
Q3 		$968K Buy
+8,188
New +$1.24M 0.91% 14
2022
Q1 		$1.42M Sell
8,251
-541
-6% -$91.1K 1.09% 14
2021
Q4 		$2.23M Sell
8,792
-801
-8% -$234K 1.59% 11
2021
Q3 		$3.69M Buy
9,593
+2,209
+30% +$815K 2.91% 6
2021
Q2 		$1.74M Buy
7,384
+524
+8% +$93.6K 1.34% 16
2021
Q1 		$898K Sell
6,860
-493
-7% -$71.4K 0.74% 24
2020
Q4 		$768K Sell
7,353
-6,906
-48% -$699K 0.26% 37
2020
Q3 		$1.01M Buy
14,259
+2,600
+22% +$181K 0.42% 36
2020
Q2 		$749K Buy
+11,659
New +$639K 0.38% 38

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stevard LLC's MRNA Position: Q3 2024 in Review

Stevard LLC sold out of Moderna (MRNA) in Q3 2024, closing a stake of 7,350 shares — an estimated $873K sold.

Stevard LLC first reported a position in MRNA in Q2 2020 and held it in 16 quarters. The position peaked at $3.69M in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Stevard LLC reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Stevard LLC sold 7,350 Moderna shares in Q3 2024, an estimated $873K.
  • Stevard LLC first reported a position in Moderna in Q2 2020 and held it in 16 quarters.
  • Stevard LLC's Moderna position peaked at $3.69M in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Stevard LLC's 13F filing for Q3 2024, filed 14 Nov 2024.